PSY16 COST-EFFECTIVENESS OF TOFACITINIB IN ACTIVE PSORIATIC ARTHRITIS AFTER CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS TREATMENT IN SPAIN
Abstract
Authors
M. Vázquez J.D. Cañete J. Nicolas C. Peral S. Gómez A. López M. Prades F. Rebollo